Ultragenyx Pharmaceutical | Despesa De Juros Sobre A Dívida



Interest Expense On Debt Alterar Data
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 38.97M 4.6M 2024-12
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Insmed USD 19.8M 532K 2024-12
Ionis Pharmaceuticals USD 2.59M 70K 2024-12
Kyowa Hakko Kirin 979M 906.1M 2024-09
MacroGenics USD -24000 24K 2024-12
Moderna USD 6M 0 2024-12
Neurocrine Biosciences USD 1.1M 0 2024-03
PTC Therapeutics USD 42.11M 1.09M 2024-09
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



Ultragenyx Pharmaceutical Despesa De Juros Sobre A Dívida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.